The Government Just Ended FICO’s Mortgage Monopoly. Here’s What It Means for Borrowers

Thank you for being a Global Market News subscriber.

The Government Just Ended FICO’s Mortgage Monopoly. Here’s What It Means for Borrowers

Mortgage lenders finally have another option, and the impact could reach far beyond credit scores. Some borrowers may qualify for better terms, while Wall Street is already repricing one of the biggest names in consumer credit.

👉 Get the Full Details

Having Trouble Hearing Phone Calls?

Read what callers are saying as they speak — at no cost if you qualify.

ClearCaptions turns your phone conversations into easy-to-read captions in real time, so you can hear the caller and read their words at the same time.

If you have hearing loss, you may qualify for:

There’s no cost to qualified users through a federally managed program.

Don’t miss another important word from family, friends or your doctor.

👉 See If You Qualify for a Free Phone

4 Retirement Account Mistakes That Can’t Be Undone

Most IRA errors can be fixed. These four generally can’t, and a seemingly minor mistake while moving retirement money could trigger taxes, penalties or both.

👉 Read the Details

The Unemployment Rate Looks Fine. The Job Market Doesn’t.

Layoffs remain low, but hiring is slowing and workers are increasingly staying put. The numbers beneath the headline unemployment rate reveal a labor market that may be weaker than it appears.

👉 Read the Details

Power of FDA Breakthrough Designation for Sepsis

The FDA doesn't grant Breakthrough Device Designation easily. It’s reserved for technologies with the potential to address life-threatening conditions, granting prioritized regulatory pathway.

Eliaz Therapeutics has earned this title for XGal-3®, an investigational sepsis device that is advancing toward human clinical trials next year.

This device targets Galectin-3, a protein that’s a key driver in the sepsis immune response, removing it directly from the bloodstream before organ failure sets in. Sepsis is a $100B/year problem, and there is currently no FDA-approved therapy that targets the cause. Not yet, at least.

Eliaz Therapeutics has 75+ patents across 30+ countries and a global collaboration with a world leader in medical technology, Terumo BCT.

And right now, you have the opportunity to back this technology before it potentially reaches the market.

👉 Invest in Eliaz Therapeutics Today

Trump Announces $15 Billion Iowa Steel Plant That Could Become America’s Largest

A massive new industrial project is being pitched as a major expansion of U.S. steelmaking. The size of the investment, potential jobs and broader manufacturing implications make this one worth watching.

👉 Read the Details

Your Insurance Company Is Counting on You Not Shopping Around.

Many drivers simply renew their policy without checking whether a better rate is available.

This free tool compares quotes from more than 100 insurers in minutes, helping you see if you could save before your next bill arrives.

No obligation.
No phone calls required.

👉 Check Your Rate for Free